(Q73694646)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296219%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

A phase II trial of circadian-timed paclitaxel and cisplatin therapy in metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296219%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

main subject

phase II clinical trial

1 reference

inferred from title

metastatic breast cancer

1 reference

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296219%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

A Ezzat

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296219%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M A Raja

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296219%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J Berry

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296219%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

F Zwaan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296219%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Rahal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296219%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A el-Warith

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296219%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 July 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296219%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296219%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296219%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296219%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

663-667

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296219%20AND%20SRC:MED&resulttype=core&format=json

Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228121390

7 January 2021

Circadian cancer therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228121390

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228121390

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228121390

7 January 2021

Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228121390

7 January 2021

Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228121390

7 January 2021

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228121390

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228121390

7 January 2021

Sequences of taxol and cisplatin: a phase I and pharmacologic study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228121390

7 January 2021

Circadian changes in estimated hepatic blood flow in healthy subjects

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228121390

7 January 2021

Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228121390

7 January 2021

Identifiers

DOI

10.1023/A:1008228121390

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296219%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference